Variant report
Variant | nsv511215 |
---|---|
Chromosome Location | chr3:98899033-98902911 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ST3GAL6-6 | chr3:98899387-98899480 | NONHSAT090838 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4928154 | chr3:98899033-98899034 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs371613489 | chr3:98899063-98899064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs57596515 | chr3:98899064-98899065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs57276984 | chr3:98899066-98899067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376736785 | chr3:98899155-98899156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141784591 | chr3:98899159-98899160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369790843 | chr3:98899226-98899227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374207310 | chr3:98899236-98899237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377628782 | chr3:98899245-98899246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369329566 | chr3:98899246-98899247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373692609 | chr3:98899248-98899249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376324850 | chr3:98899255-98899256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370400878 | chr3:98899260-98899261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373570092 | chr3:98899267-98899268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377527190 | chr3:98899268-98899269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370954040 | chr3:98899269-98899270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs374370047 | chr3:98899270-98899271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368303108 | chr3:98899274-98899275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371753375 | chr3:98899275-98899276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs374746903 | chr3:98899278-98899279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs367910107 | chr3:98899283-98899284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371827302 | chr3:98899287-98899288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374842338 | chr3:98899290-98899291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370025812 | chr3:98899292-98899293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372684989 | chr3:98899303-98899304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150455860 | chr3:98899347-98899348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138241072 | chr3:98899434-98899435 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs547621330 | chr3:98899683-98899684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536893669 | chr3:98900014-98900015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552338073 | chr3:98900143-98900144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570611760 | chr3:98900165-98900166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111706229 | chr3:98900188-98900189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547684921 | chr3:98902330-98902331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371249884 | chr3:98902389-98902390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7641092 | chr3:98902395-98902396 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs774973 | chr3:98902416-98902417 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs76157764 | chr3:98902432-98902433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs398091671 | chr3:98902437-98902438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs200556058 | chr3:98902438-98902439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116192946 | chr3:98902456-98902457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188148368 | chr3:98902505-98902506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201886641 | chr3:98902519-98902520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9857240 | chr3:98902532-98902533 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs535526680 | chr3:98902540-98902541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555078196 | chr3:98902578-98902579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs7629965 | chr3:98902589-98902590 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs139406779 | chr3:98902620-98902621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184276535 | chr3:98902631-98902632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs577098774 | chr3:98902636-98902637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142637360 | chr3:98902657-98902658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 21858020 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:98879200-98899200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr3:98899200-98899600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr3:98899200-98899600 | Enhancers | NHEK | skin |
4 | chr3:98899200-98900200 | Enhancers | HMEC | breast |
5 | chr3:98901800-98912400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |